Aventis Pasteur, Merck Sharp & Dohme Phils., GlaxoSmithKline and Zuellig Pharma donated the vaccines through the Zuellig Foundation as their contribution to the fight against the disease.
Those who witnessed the turnover ceremony are:(from left) Dr. Joselito Sta. Ana, director-Sales and Marketing, Aventis Pasteur; Karen Villanueva, manager-Corporate-Relations, Zuellig Pharma; Paul-Alan Dollinger, country manager, Aventis Pasteur; Noel Isberto, vice president, Corporate Affairs, GlaxoSmithKline; and Christine Liwanag, director, Corporate Communications and Services, Merck harp & Dohme Phils.